Repligen CorporationStock Price and Value Analysis

Should you buy Repligen Corporation stock? (NasdaqGS:RGEN). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This stock looks overpriced.
  • This company is less known than others.
  • This company is not making money.
  • This company pays no dividend.

Inside the RGEN Numbers

RGEN Price
(Repligen Corporation stock price per share)
$35.56
[?] PE Ratio versus Sector 207% higher than other Healthcare stocks
[?] PE Ratio versus Industry 7% higher than other Biotechnology stocks
[?] Free Cash Flow Jitter 0%

Is Repligen Corporation Stock on Sale?

Based on our analysis, we believe that you should not buy Repligen Corporation right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy RGEN Stock?

Does Repligen Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.